ClinicalTrials.govpublic full text
Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea
multiple myeloma, pomalyst®, pomalidomide, observational, korea, post marketing surveillance[pms], relapsed and refractory multiple myeloma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980885
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.